Elevated serum neutrophil elastase is related to prehypertension and airflow limitation in obese women

BMC Women's Health

Volumn 11, Issue , 2011, Pages

  El Eshmawy, Mervat M ^a   El Adawy, Eman H ^a   Mousa, Amany A ^a   Zeidan, Amany E ^b   El Baiomy, Azza A ^b   Abdel Samie, Elham R ^b   Saleh, Omayma M ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEUKOCYTE ELASTASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; AGE; AIRFLOW; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; OBESITY; PREHYPERTENSION; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; BLOOD; COMPARATIVE STUDY; ENZYMOLOGY; LUNG VENTILATION; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RISK FACTOR; WOMEN'S HEALTH;

ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOCYTE ELASTASE; MIDDLE AGED; OBESITY; PREHYPERTENSION; PULMONARY VENTILATION; RISK FACTORS; WOMEN'S HEALTH;

EID: 78651491708     PISSN: None     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-11-1     Document Type: Article

References (58)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure: The JNC 7 Report. JAMA 2003, 289:2560. 10.1001/jama.289.19.2560, 12748199.
2. Greenlund KJ, Groft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch - Intern Med 2004, 164:2113. 10.1001/archinte.164.19.2113, 15505124.
3. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lacent 2001, 358:1682-1686.
4. Liszka HA, Mainous AG, King DE, Everett CJ, Egan BM. Prehypertension and cardiovascular morbidity. Ann Fam Med 2005, 3:294-299. 10.1370/afm.312, 1466908, 16046560.
5. Lenfant C, Chobanian AV, Janes DW, Roccella EJ. Seventh report of the joint national committee on the prevention, detection, evaluation and treatment of high blood pressure (JNC7): Resetting the hypertension sail - Hypertension. 2003, 41:1178-1179.
6. Janoff A, Scherer J. Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activity in granules of human polymorphonuclear leukocytes. J Exp Med 1968, 128:1137-1155. 10.1084/jem.128.5.1137, 2138566, 5303065.
7. Belaaouaj AA, McCarthy R, Baumann M, Ley Gaoz TJ, Abraham SN, Shapiro SD. Mice lacking neturophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med 1998, 4:615-618. 10.1038/nm0598-615, 9585238.
8. Garica R, Gusmanil L, Murgia R, Guarnaccia C, Cinco M, Rottini G. Elastase is the only human neutrophil granule protein that alone is responsible for the in vitro killing of borrelia burgdoferi. Infect Immun 1998, 66:1408-1412. 108067, 9529060.
9. Tkalcevic J, Novelli M, phylactides M, Iredale JP, Segal AW, Roes AW, Roes J. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity 2000, 12:201-210. 10.1016/S1074-7613(00)80173-9, 10714686.
10. Robert L, Robert AM, Tacotot B. Elastin-elastase-athersclerosis revisited. Atherosclerosis 1998, 140:81-95. 10.1016/S0021-9150(98)00171-3, 9733218.
11. Siedle B, Cisielski S, Murillo R, Löser B, Castro V, Klaas CA, Hucke O, Labahn A, Melzig MF, Merfort I. Sesquiterpene lactones as inhibitors of human neutrophil elastase. Bioorg Med Chem 2002, 10:2855-2861. 10.1016/S0968-0896(02)00149-9, 12110305.
12. Bedard M, McClure CD, Schiller NL, Francoeur C, Cantin A, Denis M. Release of interleukin-8, interleukin-6 and colony stimulating factors by upper airway epithelial cells: implications for cystic fibrosis. Am J Respir cell Mol Biol 1993, 9:455-63.
13. Lee WL, Downey GP, . Leukocyte elastase physiological functions and role in acute lung injury. Am J Respir Crit Care Med 2001, 164:896-904. Leukocyte elastase.
14. Turino GM, Seniorrm, Garg BD, Keller S, Levi MM, Mandl I. Serum elastase inhibitor deficiency and a1-anti trypsin deficiency in patients with obstructive emphysema. Science 1969, 165:709-711. 10.1126/science.165.3894.709, 5793975.
15. Gettins PG. Serpin structure, mechanism, and function. Chem Rev 2002, 102:4751-804. 10.1021/cr010170+, 12475206.
16. Hornebeck W, potazman JP, De Cremoux H, Bellon G, Robert L. Elastase-type activity of human serum: its variation in chronic obstructive lung diseases and atherosclerosis. Clin physiol Biochem 1983, 1:285-592.
17. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit care Med 1995, 151:1075-1082.
18. Owen CA, Campbell EJ. The cell biology of leukocyte mediated proteolysis. J Leukoc Biol 1999, 65:137-150.
19. Bizbiz L, Bonithon-Kopp C, Ducimetiere' P, Berrc, Alperovitch A, Robert L. Relation of serum elatase activity to ultrasonographyically assessed carotid artery wall lesions and cardiovascular risk factors. The EVA study. Atherolersosis 1996, 120:47-55.
20. Yasmin MCM, Wallace S, Dakham Z, pulsalkar P, Maki-Petaja K, Ashby MJ, Cockcroft JR, Wilkinson IB. Matrix metalloproteinase-9 (MMP-9), MMp-2 and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol 2005, 25:372. 10.1161/01.ATV.0000151373.33830.41, 15556929.
21. Gardiner PJ. Neutrophil elastase inhibitors. Eur Respir Rev 2002, 12:373-374.
22. Friedewald WT, Levy RT, Fredrickson DS. Estimation of the concentration of low- density lipoprotein cholesterol without the use of preparative ultracentrifuge. Clin Chem 1972, 18:499.
23. Oremek, et al. MTA 1995, 10:273-278.
24. Kimberly MM, Vesper HW, Caudill SP, Cooper GR, Rifai N, Dati F, Myers GL. Standardization of immunoassay for measurement of high-sensitivity C reactive protein phase 1: Evaluation of secondary reference materials. Clin Chem 2003, 49:611-616. 10.1373/49.4.611, 12651814.
25. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J 2005, 26:319-38. 10.1183/09031936.05.00034805, 16055882.
26. Beilin LJ. Non-pharmacological management of hypertension: Optimal strategies for reducing cavdiovascular risk. J Hypertens 1994, 12:S71-S81.
27. Yang G, Shu XO, Gao YT, Zhang X, Li H, Zheng W. Impacts of weight change on prehypertension in middle-aged and elderly women. Int J Obes 2007, 31:1818-1825.
28. Okosun IS, Boltri JM, Anochie LK, Chandra KMD. Racial/ethnic differences in prehypertension in American adults: population and relative attributable risk of abdominal obesity. J Hum Hypertens 2004, 18:849-855. 10.1038/sj.jhh.1001771, 15361887.
29. Zhang Y, Lee ET, Devereux RB, Yeh J, Best LG, Fabsitz RR, Howard BV. Prehypertension, diabetes and cardiovascular disease risk in a population-based sample: The strong Heart Study. Hypertension 2006, 47:410-414. 10.1161/01.HYP.0000205119.19804.08, 16446387.
30. Leone N, Courbon D, Thomas F, Bean K, Jégo B, Leynaert B, Guize L, Zureik M. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med 2009, 179:509-516. 10.1164/rccm.200807-1195OC, 19136371.
31. Nicoloff G, Christova P. Elastin degradation products among obese children with family history of arterial hypertension. Diabetologia croatica 2003, 32-1.
32. Nicoloff G, Petrova C, Dimitrova-Laleva P, Christova P. Increased elastin turnover in obese and diabetic children with vascular complications. Diabetologia croatica 2003, 32-2.
33. Piwowar A, Knapik-Kordecka M, Warwas M. Concentration of leukocyte elastase in plasma and polymorphouclear neutrophil Extracts in type 2 diabetes. Clin Chem Lab Med 2000, 38:1257-1261. 10.1515/CCLM.2000.198, 11205690.
34. Adeyemi E, Benedicts, Abdulle A. A comparison of plasma polymorphonuclear leucocyte elastase levels in obese and lean individuals. J Int Med Res 1998, 26:252-256.
35. Keeley FW, Alatawi A. Response of aortic elastin synthesis and accumulation to developing hypertension and the inhibitory effect of cochicine on this response. Lab Invest 1991, 64:499-507.
36. Rana JS, Nieuwdorp M, Jukema JW, Kastelein JJ. Cardiovascular metabolic syndrome-interplay of obesity, inflammation, diabetes and coronary heart disease. Diabetes obes Metab 2007, 9:218-232. 10.1111/j.1463-1326.2006.00594.x, 17391148.
37. Chrysohoou C, Pitsavos C, Ponagiotakos DB, Skoumas J, Stefanadis C. Association between prehypertension status and inflammatory markers related to altheosclerotic disease. Am J Hypertens 2004, 17:568-573. The ATTICA Study, 10.1016/j.amjhyper.2004.03.675, 15233975.
38. King DE, Egan BM, Mainous AG, Geesey ME. Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens 2004, 6:562-568.
39. Mania-pramanik J, potdar SS, Vadigoppula A, Sawant S. Elastase: a predictive matter of inflammation and/or infection. J Clin Lab Anal 2004, 18:153-158. 10.1002/jcla.20015, 15103678.
40. Nicoloff G, Petkova-Botzova M, Baydanoff S. Serum levels of elastin and collagen-derived peptides in children with high risk of atherosclerosis. Int J Obes 1995, 19:120.
41. Paczek L, Michalska W, Bartlomiejczyk I. Trypsin, elastase, plasmin and MMP-9 activity in the serum during the human ageing process. Age ageing 2008, 37:318-323. 10.1093/ageing/afn039, 18332058.
42. Antonicelli F, Bellon G, Debelle L, Hornebeck W. Elastin- elastases and inflamm-aging. Curr Top Dev Biol 2007, 79:99-155. full_text, 17498549.
43. Lazarus R, Sparrow D, Weiss ST. Effect of obesity and fat distribution on ventillatory function: the normative aging study. Chest 1997, 111:91-98.
44. Bach JF, Rozanski EA, Bedenice D, et al. Association of expiratory airway dysfunction with marked obesity in healthy adult dogs. Am J Vet Res 2007, 68:670-675. 10.2460/ajvr.68.6.670, 17542702.
45. Sin DD, Jones RI, Man SF. Obesity is a risk factor for dyspnea but not for air flow obstruction. Arch Intern Med 2002, 162:1477-1481. 10.1001/archinte.162.13.1477, 12090884.
46. Suzuki T, Wang W, Lin JT, Shirato K, Mitsuhashi H, Inoue H. Aerosolized human neutrophil elastase induces airway constriction and hyperresponsiveness with protection by intravenous pretreatment with half- length secretory leukprotease inhibitor. Am J Respir Crit Care Med 1996, 153:1405-11.
47. Parks WC, Shapiro SD. Matrix metalloproteinases in lung biology. Respir Res 2001, 2:10-19. 10.1186/rr33, 59564, 11686860.
48. Owen CA. Proteinases and oxidants as targets in the treatment of obstructive pulmonary disease. Proc Am Thorac Soc 2005, 2:373-385. 10.1513/pats.200504-029SR, 2713328, 16267366.
49. Ganguly SS, Al-Shafaee MA, Bhargava K, Duttagupta KK. Prevalence of prehypertension and associated cardiovascular risk profiles among prediabetic Omani adults. BMC Public Health 2008, 8:108. 10.1186/1471-2458-8-108, 2386813, 18394173.
50. Grotto I, Grossman E, Huerta M, Sharabi Y. Prevalence of prehypertension and associated cardiovascular risk profiles among young Israeli adults. Hypertension 2006, 48:254-272. 10.1161/01.HYP.0000227507.69230.fc, 16754794.
51. Bonithon-Kopp C, Touboul PJ, Berr C, Magne C, Ducimetière P, et al. Factors of carotid arterial enlargement in a popular aged 59 to 71 years. Stoke 1996, 27:654-660.
52. BizBiz L, Bonithon-Kopp C, Ducimetiere P, Berr C, AlperOvitch A, Robert L. Relation of serum elastase activity to ultrasonographically assessed carotid artery wall lesions and cardiovascular risk factors. The EVA study Atherosclerosis 1996, 120:47-55.
53. Landi A, Bihari-Varga M, Keller L, Mezey Z, Gruber E. Elastase - type enzymes and their relation to blood lipids in atherosclerotic patients. Atherosclerosis 1992, 93:17-23. 10.1016/0021-9150(92)90196-N, 1596301.
54. Bihari-Varga M, Keller L, Landi A, Robert L. Elastase-type activity, elastase inhibitory capacity, lipids and lipoproteins in the sera of patients with ischemic vascular disease. Atherosclerosis 1984, 50:273-81. 10.1016/0021-9150(84)90075-3, 6561958.
55. Polacek D, Byrne RE, Fless GM, Scanu AM. In vitro proteolysis of human plasma low density lipoproleins by an elastase released from human blood polymorphonuclear cells. J Biol Chem 1986, 261:2057-2063.
56. Zureik M, Robert L, Courbon D, Touboul PJ, Bizbiz L, Ducimetiere P, . Serum elastase activity serum elastase inhibitors, and occurrence of carotid Atherosclerotic plagues. Circulation 2002, 105:2638-2645. 10.1161/01.CIR.0000017329.51160.EF, 12045170, Serum elastase activity.
57. Kakuta J, Aoshiba K, Nagi A. C-reactive protein products generated by neutrophil elastase promote neutrophil apoptosis. Arch Med Res 2006, 37:456-460. 10.1016/j.arcmed.2005.10.010, 16624642.
58. Bizeto L, Mazzolini AB. Ribeiro: Interrelationship between serum and sputum inflammatory mediators in chronic obstructive pulmonary disease. Braz J Med Biol Res 2008, 41:193-198. 10.1590/S0100-879X2008005000010, 18327434.